Reinforcing the potential importance of TNF-α in HD pathogenesis, it has recently been shown that therapeutic inhibition of TNF-α activity can significantly attenuate central and peripheral inflammation in the R6/2 HD model mice (149). Here, TNF is linked to Huntington disease.